Heilongjiang ZBD Pharmaceutical Co Ltd (603567) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥283.54 Million ≈ $41.49 Million USD) by net assets (CN¥7.29 Billion ≈ $1.07 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Heilongjiang ZBD Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.

Heilongjiang ZBD Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Heilongjiang ZBD Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Heilongjiang ZBD Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heilongjiang ZBD Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
mobilezone ag SW:MOZN	-1.383x
Ningbo Sinyuan ZM Technology Co. Ltd. A SHE:301398	N/A
Guizhou Transp Planning SHG:603458	0.028x
Sido Muncul PT JK:SIDO	0.126x
PIMCO Access Income Fund NYSE:PAXS	N/A
Shandong Rike Chemical SHE:300214	0.022x
Patrizia AG XETRA:PAT	0.038x
Mama's Creations Inc. NASDAQ:MAMA	0.054x

Annual Cash Flow Conversion Efficiency for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Heilongjiang ZBD Pharmaceutical Co Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.29 Billion ≈ $1.21 Billion	CN¥164.31 Million ≈ $24.04 Million	0.020x	+134.80%
2023-12-31	CN¥8.04 Billion ≈ $1.18 Billion	CN¥-457.90 Million ≈ $-67.00 Million	-0.057x	-23.85%
2022-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥-326.79 Million ≈ $-47.82 Million	-0.046x	+25.28%
2021-12-31	CN¥7.05 Billion ≈ $1.03 Billion	CN¥-433.94 Million ≈ $-63.50 Million	-0.062x	-318.25%
2020-12-31	CN¥5.50 Billion ≈ $805.28 Million	CN¥155.18 Million ≈ $22.71 Million	0.028x	-32.99%
2019-12-31	CN¥5.25 Billion ≈ $768.26 Million	CN¥220.92 Million ≈ $32.33 Million	0.042x	-42.93%
2018-12-31	CN¥4.98 Billion ≈ $729.21 Million	CN¥367.40 Million ≈ $53.76 Million	0.074x	-59.57%
2017-12-31	CN¥4.68 Billion ≈ $684.71 Million	CN¥853.19 Million ≈ $124.85 Million	0.182x	+4862.02%
2016-12-31	CN¥4.31 Billion ≈ $630.20 Million	CN¥15.83 Million ≈ $2.32 Million	0.004x	+104.52%
2015-12-31	CN¥3.98 Billion ≈ $582.63 Million	CN¥-323.90 Million ≈ $-47.40 Million	-0.081x	-145.75%
2014-12-31	CN¥2.17 Billion ≈ $317.92 Million	CN¥386.32 Million ≈ $56.53 Million	0.178x	+77.83%
2013-12-31	CN¥1.75 Billion ≈ $255.64 Million	CN¥174.68 Million ≈ $25.56 Million	0.100x	-14.48%
2012-12-31	CN¥1.32 Billion ≈ $193.04 Million	CN¥154.25 Million ≈ $22.57 Million	0.117x	+3.07%
2011-12-31	CN¥923.09 Million ≈ $135.08 Million	CN¥104.71 Million ≈ $15.32 Million	0.113x	--

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic

Market Cap

$644.42 Million

CN¥4.40 Billion CNY

Market Cap Rank

#11135 Global

#3155 in China

Share Price

CN¥4.68

Change (1 day)

-7.87%

52-Week Range

CN¥4.68 - CN¥13.15

All Time High

CN¥28.17